Erenumab is prescribed for:
- Migraine prevention
- Reducing frequency of migraine attacks
- Neurologic headache management
It's a first-in-class CGRP receptor antagonist for migraine prevention.
Back to Medication Guide
Erenumab
Generic Name: Erenumab-aooe
Brand Names: Aimovig
Erenumab is a CGRP inhibitor given as a monthly injection to prevent migraine headaches.
NeurologicMigraine Prevention
What It's Used For
Side Effects
Common side effects:
- Injection site reactions
- Constipation
- Muscle cramps
Serious side effects:
- Severe constipation
- Hypertension
- Hypersensitivity reactions
Additional Information
What is Erenumab?
Erenumab is the first FDA-approved CGRP inhibitor for migraine prevention.
Mechanism
CGRP (calcitonin gene-related peptide) plays a key role in migraine. Erenumab blocks CGRP receptors to prevent migraine attacks.
Administration
Self-administered monthly injection. Available in 70 mg and 140 mg doses.
Effectiveness
Can reduce monthly migraine days by 50% or more in many patients.
For more information, see MedlinePlus.
Related Health Conditions
This medication is commonly used to treat or manage the following conditions:
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Ask Dr. Zimmer
Have questions about Erenumab? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.